AlloSource Completes ProChondrix Study Milestone

AlloSource ProChondrix

The first patients have completed 12-month follow-up in AlloSource's five-year study, A Prospective, Multi-Center Study Evaluating ProChondrix® CR for the Repair of Focal Articular Cartilage Defects in the Knee.

ProChondrix CR cryopreserved osteochondral allograft is a single-stage option to deliver the components for articular cartilage...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us